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ABSTRACT Modifications of natural DNA and synthetic oligodeoxyribonucleotide duplexes in a cell-free medium by analogs
of antitumor cisplatin containing enantiomeric amine ligands, such as cis-[PtCl2(RR-DAB)] and cis-[PtCl2(SS-DAB)] (DAB 
2,3-diaminobutane), were studied by various methods of molecular biophysics and biophysical chemistry. These methods
include DNA binding studies by pulse polarography and atomic absorption spectrophotometry, mapping of DNA adducts
using transcription assay, interstrand cross-linking assay using gel electrophoresis under denaturing conditions, differential
scanning calorimetry, chemical probing, and bending and unwinding studies of the duplexes containing single, site-specific
cross-link. The major differences resulting from the modification of DNA by the two enantiomers are the thermodynamical
destabilization and conformational distortions induced in DNA by the 1,2-d(GpG) intrastrand cross-link. It has been suggested
that these differences are associated with a different biological activity of the two enantiomers observed previously. In
addition, the results of the present work are also consistent with the view that formation of hydrogen bonds between the
carbonyl oxygen of the guanine residues and the “quasi equatorial” hydrogen of the cis amine in the 1,2-d(GpG) intrastrand
cross-link plays an important role in determining the character of the distortion induced in DNA by this lesion.
INTRODUCTION
Since the discovery of its anticancer activity, several new
analogs of cisplatin [cis-diamminedichloroplatinum(II), cis-
PtCl2(NH3)2] have been synthesized and tested for biolog-
ical activity. Some of these compounds are now considered
potent anticancer drugs (Pasini and Zunino, 1987; Bloemink
and Reedijk, 1996; Reedijk, 1996; O’Dwyer et al., 1999).
Although the precise mechanism of antitumor action of
platinum drugs is not completely understood, they are
known to target DNA primarily by forming bifunctional
adducts (Pinto and Lippard, 1985; Johnson et al., 1989). The
anticancer activity displayed by cisplatin and its analogs is
usually attributed to a unique type of intrastrand d(GpG)
adduct with platinum cross-linking N7 atoms of neighbor-
ing guanine residues of DNA. It has been also shown that
carrier amine ligands of cisplatin analogs appear to modu-
late the antitumor properties of this class of drugs. The
antitumor activity is usually lost or diminished if the pri-
mary or secondary amines on platinum are replaced by
tertiary amines (Sundquist and Lippard, 1990).
There are many possible roles for the carrier ligand of the
platinum antitumor compounds. Hydrogen bonding be-
tween DNA and the carrier ligand could affect the initial
attack of DNA by the drug and the type of DNA cross-
linking (intra or interstrand). It is also reasonable to expect
that the direction (5 or 3) of closure of monofunctional
DNA adducts (formed in the first step of their binding to
DNA) into cross-links is affected by hydrogen bonding. In
addition, the carrier ligand may also affect biodistribution,
and recognition of DNA adducts by repair enzymes, regu-
latory and/or DNA-binding proteins.
The biological activity of platinum complexes with en-
antiomeric amine ligands such as cis-[PtCl2(RR-DACH)]
and cis-[PtCl2(SS-DACH)] (DACH  1,2-diaminocyclo-
hexane) and other enantiomeric pairs has been intensively
investigated (Kidani et al., 1978; Noji et al., 1981, 1983;
Coluccia et al., 1986, 1991; Fanizzi et al., 1987; Pasini and
Zunino, 1987; Giannini and Natile, 1991; Vickery et al.,
1993; Fenton et al., 1997). For instance, the DACH carrier
ligand has been shown to significantly affect the ability of
platinum-DNA adducts to block essential processes such as
replication and transcription (Page et al., 1990). Also im-
portantly, cis-[PtCl2(N-N)] complexes with N-N  DACH
or 1,2-diaminopropane (DAB) having an S configuration at
the asymmetric carbon atoms were markedly more muta-
genic toward several strains in Salmonella typhimurium
than their R isomers (Fanizzi et al., 1987). Hence, although
the asymmetry in the amine ligand in these platinum com-
plexes did not involve the coordinated nitrogen atom, but
rather an adjacent carbon atom, a dependence of the bio-
logical activity on the configuration of the amine was
observed.
The major DNA adduct of cisplatin and its analogs is an
intrastrand d(GpG) cross-link (Sherman and Lippard, 1987;
Bloemink and Reedijk, 1996). It has been demonstrated that
this cross-link adopts an anti, anti head-to-head (HH) con-
formation in both single- and double-stranded DNA. How-
ever, it has been speculated in numerous reports that this
conformer equilibrates with other forms that interconvert
too rapidly for separate characterization by NMR spectros-
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copy (Den Hartog et al., 1982; Neumann et al., 1984; Kline
et al., 1989; Mukundan et al., 1991; Berners-Price et al.,
1996, 1997; Van Boom et al., 1996). The dynamic character
of the platinum-DNA adduct makes establishing a correla-
tion between its stereochemistry and the configuration of
the carrier ligand difficult.
In the present work modifications of DNA by cis-
[PtCl2(DAB)] enantiomers (Fig. 1) in cell-free media were
investigated by using various techniques of molecular bio-
physics. The goal of these studies was to contribute to
understanding how the chirality at the carbon atoms of the
carrier ligand in cisplatin analogs can affect their biological
activity. cis-[PtCl2(DAB)] isomers were chosen for the
studies described in the present paper as the representatives
of platinum drugs with enantiomeric amine ligands because
the effect of different chirality at the carbon atoms on the
biological activity was most pronounced in the case of these
compounds. The effect of the configuration of the carrier
diamine in cis-[PtCl2(DAB)] complexes with R, R and S, S
configurations at the asymmetric carbons [these complexes
are abbreviated as Pt-DAB(RR) and Pt-DAB(SS), respec-
tively] was investigated. A schematic representation of the
puckering of the chelate rings in Pt-DAB(RR) or Pt-
DAB(SS) isomers is shown in Fig. 1.
MATERIALS AND METHODS
Starting materials
Cisplatin was synthesized and characterized in Lachema (Brno, Czech
Republic). Pt-DAB(RR) and Pt-DAB(SS) complexes were prepared and
characterized as described previously (Fanizzi et al., 1987). The stock
solutions of the platinum complexes (5 104 M in 10 mM NaClO4) were
prepared in the dark at 25°C. Calf thymus (CT) DNA (42% G  C, mean
molecular mass 2 107 Da) was also prepared and characterized as
described previously (Brabec and Palecˇek, 1970, 1976). Plasmid pSP73KB
[2455 bp (Lemaire et al., 1991)] was isolated according to standard
procedures and banded twice in CsCl/EtBr equilibrium density gradients.
The synthetic oligodeoxyribonucleotides were synthesized and purified as
described previously (Brabec et al., 1992). Restriction endonucleases, T4
DNA ligase, Klenow fragment of DNA polymerase I, and T4 polynucle-
otide kinase were purchased from New England Biolabs (Beverly, MA).
Riboprobe Gemini System II for transcription mapping containing SP6 and
T7 RNA polymerases was purchased from Promega (Madison, WI).
Ethidium bromide, agarose, acrylamide, bis(acrylamide), and NaCN were
from Merck KgaA (Darmstadt, Germany). Dimethyl sulfate (DMS),
KMnO4, diethylpyrocarbonate (DEPC), KBr, and KHSO5 were from
Sigma, Prague. [-32P]ATP and [-32P]dATP were from Amersham (Ar-
lington Heights, IL).
Platination reactions
CT DNA and plasmid DNAs were incubated with the platinum complex in
10 mM NaClO4 at 37°C for 48 h in the dark if not stated otherwise. The
number of molecules of the platinum compound bound per nucleotide
residue (rb values) were determined by flameless atomic absorption spec-
trophotometry (FAAS) or by differential pulse polarography (DPP) (Kim et
al., 1990). The oligonucleotides were allowed to react with the platinum
compounds, and repurified as described previously (Brabec et al., 1992).
Briefly, the oligonucleotides synthesized on an Applied Biosystems solid-
phase synthesizer were purified by ion-exchange FPLC. The single-
stranded oligonucleotides (the top strands in Fig. 1) were reacted in
stoichiometric amounts with Pt-DAB(RR) or Pt-DAB(SS). The platinated
oligonucleotides were purified by FPLC. It was verified by platinum FAAS
and by the measurements of the optical density that the modified oligonu-
cleotides contained one platinum atom. It was also verified using DMS
footprinting of platinum on DNA (Lemaire et al., 1991; Brabec and Leng,
1993) that in the platinated top strands the N7 position of both neighboring
guanines was not accessible for reaction with DMS. Briefly, platinated and
nonmodified top strands (5-end-labeled with 32P) were reacted with DMS.
DMS methylates the N7 position of guanine residues in DNA, producing
alkali-labile sites (Maxam and Gilbert, 1980). However, if N7 is covalently
bound to platinum, it cannot be methylated. The oligonucleotides were then
treated with hot piperidine and analyzed by denaturing polyacrylamide gel
electrophoresis. For the nonmodified oligonucleotides, shortened frag-
ments due to the cleavage of the strand at the two methylated guanine
residues were observed in the gel. However, no such bands were detected
for the platinated oligonucleotides. These results indicate that one Pt-DAB
molecule was coordinated to neighboring guanine residues, forming the
1,2-d(GpG) intrastrand cross-link. The platinated strands were allowed to
anneal with nonplatinated complementary strands (the bottom strands in
Fig. 1) in 50 mM NaCl plus 1 mM Tris  HCl with 0.1 mM EDTA, pH 7.4.
FPLC purification and FAAS measurements were carried out on a Phar-
macia Biotech FPLC System with a MonoQ HR 5/5 column and a Unicam
939 AA spectrometer equipped with a graphite furnace, respectively.
DNA transcription by RNA polymerases in vitro
Transcription of the (NdeI/HpaI) restriction fragment of pSP73KB DNA
with SP6 and T7 RNA polymerases and electrophoretic analysis of tran-
FIGURE 1 Structures of Pt-DAB(RR) and Pt-DAB(SS), and sequences
of the synthetic oligodeoxyribonucleotides used in the present study with
their abbreviations. The top and bottom strands of each pair are designated
top and bottom, respectively, in the text. The bold letters in top strands
indicate the location of the intrastrand cross-link after modification of the
oligonucleotides by Pt-DAB complexes in the way described in the Ex-
perimental section.
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scripts was performed according to the protocols recommended by Pro-
mega [Promega Protocols and Applications, 43-46 (1989/90)] and previ-
ously described in detail (Lemaire et al., 1991; Brabec and Leng, 1993).
Interstrand cross-link assay
If not stated otherwise, Pt-DAB(RR) or Pt-DAB(SS) at varying concen-
trations were incubated with 2 g pSP73KB DNA after it had been
linearized by EcoRI. The platinated samples were precipitated by ethanol
and the linear duplexes were then analyzed for DNA interstrand cross-links
in the same way as described in several recent papers (Farrell et al., 1990;
Lemaire et al., 1991; Brabec and Leng, 1993). The linear duplexes were
first 3-end-labeled by means of a Klenow fragment of DNA polymerase I
and [-32P]dATP. The samples were deproteinized by phenol, precipitated
by ethanol, and the pellet was dissolved in 18 l of 30 mM NaOH with 1
mM EDTA, 6.6% sucrose, and 0.04% bromophenol blue. The amount of
interstrand cross-links was analyzed by electrophoresis under denaturing
conditions on alkaline agarose gel (1.5%). After the electrophoresis was
completed, the intensities of the bands corresponding to single strands of
DNA and interstrand cross-linked duplex were quantified by means of a
Molecular Dynamics Phosphor Imager (Storm 860 system with Image-
Quant software). The frequency of interstrand cross-links, F (the number of
interstrand cross-links per adduct), was calculated as F  XL/4910  rb
(pSP73KB plasmid contained 4910 nucleotide residues). XL is the number
of interstrand cross-links per one molecule of the linearized DNA duplex
which was calculated assuming Poisson distribution of the interstrand
cross-links as XL  ln A, where A is the fraction of molecules running
as a band corresponding to the non-cross-linked DNA (Farrell et al., 1990).
Differential scanning calorimetry
Excess heat capacity (Cp) versus temperature profiles for the thermally
induced transitions of d(TGGT)/d(ACCA)(20-DSC) duplex unmodı´fied or
containing a unique 1,2-d(GpG) intrastrand cross-link of Pt-DAB(RR) or
Pt-DAB(SS) were measured by using a VP-DSC Calorimeter (Microcal,
Northampton, MA). In these experiments the heating rate was 60°C/h.
Transition enthalpies (H) and entropies (S) were calculated from the
areas under the experimental Cp versus T and the derived Cp/T versus
T curves, respectively, by using the ORIGIN version 4.1 software (Micro-
cal, Northampton, MA). The oligonucleotide duplexes at the concentration
of 5 Mwere dissolved in the buffer containing 10 mM sodium cacodylate
(pH 7.2), 100 mM NaCl, 10 mM MgCl2, and 0.1 mM EDTA. The samples
were vacuum-degassed before the measurement. The formation of 1:1
complexes between the top and bottom strand of d(TGGT)/d(ACCA)
nonmodified or containing the cross-link was verified by recording UV
absorbance mixing curves at 25°C (Poklar et al., 1996). It was also verified
in the same way as described in the previous paper (Poklar et al., 1996) that
the melting transition of both the platinated and nonmodified duplexes
were fully reversible.
Chemical modifications
The chemical probing of the conformation of the platinated oligonucleotide
duplexes with the aid of NaCN was performed as described previously
(Schwartz et al., 1990; Boudny´ et al., 1992). The top strand of the
d(TGGT)/d(ACCA)(20) nonmodified or containing the Pt-DAB intrastrand
cross-link was 5-end-labeled with [-32P]ATP by using T4 polynucleotide
kinase before it was annealed with its complementary (bottom) nonlabeled
strand. The oligonucleotide duplexes were treated with 0.2 M NaCN in 20
mM Tris  HCl, pH 8.3, and control nonmodified samples were run on a
denaturing 24% polyacrylamide/8M urea gel.
The modifications by KMnO4, DEPC, and KBr/KHSO5 were also
performed as described previously (Brabec et al., 1993; Bailly et al., 1994;
Ross and Burrows, 1996; Bailly and Waring, 1997). The top or bottom
strand of the d(TGGT)/d(ACCA)(20) was 5-end-labeled with [-32P]ATP
before it was annealed with its complementary nonlabeled strands. In the
case of the platinated oligonucleotides, platinum was removed after reac-
tion of the DNA with the probe by incubation with 0.2 M NaCN (alkaline
pH) at 45°C for 10 h in the dark.
Ligation and electrophoresis of oligonucleotides
Nonplatinated single strands (bottom strands in Fig. 1) were 5-end-labeled
with [-32P]ATP by using T4 polynucleotide kinase. Then they were
annealed with their phosphorylated complementary strands [nonplatinated
or containing 1,2-d(GpG) intrastrand cross-links of Pt-DAB compounds].
Nonplatinated and intrastrand cross-link containing duplexes were allowed
to react with T4 DNA ligase. The resulting samples along with ligated
nonplatinated duplexes were subsequently examined on 8% native poly-
acrylamide [mono:bis(acrylamide) ratio  29:1] electrophoresis gels.
Other details of these experiments were as described in previously pub-
lished papers (Koo et al., 1986; Bellon and Lippard, 1990).
RESULTS
DNA binding
Solutions of double-helical CT DNA at a concentration of
32 g/ml were incubated with Pt-DAB(RR) or Pt-DAB(SS)
at ri values of 0.01 in 10 mM NaClO4 at 37°C (ri is defined
as the molar ratio of free platinum complex to nucleotide
phosphates at the onset of incubation with DNA). At various
time intervals an aliquot of the reaction mixture was with-
drawn and assayed by DPP for the amount of platinum
bound to DNA (rb) (Kim et al., 1990). The amount of
platinum coordinated to DNA increased with time (not
shown). After 24 h, all molecules of Pt-DAB(RR) or
Pt-DAB(SS) present in the reaction mixtures were coordi-
nated to DNA [exhaustive dialysis of the samples of DNA
treated with Pt-DAB(RR) or Pt-DAB(SS) against platinum-
free background solution (10 mM NaClO4) did not affect
the amount of the platinum bound to DNA]. In these binding
reactions both enantiomers coordinated to DNA with ap-
proximately the same rate, which indicates that isomerism
in the non-leaving ligand of Pt-DAB compounds does not
significantly affect the rate of the coordination of platinum
moiety to natural double-helical DNA. The binding of Pt-
DAB(RR) or Pt-DAB(SS) to CT DNA was also quantified
in the following way. Aliquots of the reaction withdrawn at
various time intervals were quickly cooled on an ice bath
and then exhaustively dialyzed against 10 mM NaClO4 at
4°C to remove free (unbound) platinum compound. The
content of platinum in these samples was determined by
FAAS. Results identical to those obtained using the DPP
assay were obtained. Thus, DNA binding of Pt-DAB com-
pounds resulted within 	24 h in their complete coordina-
tion, which made it possible to prepare easily and precisely
the samples of natural DNAs or their fragments modified by
these compounds at a preselected rb value.
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In vitro transcription of DNA containing
platinum adducts
In vitro RNA synthesis by RNA polymerases on DNA
templates containing several types of bifunctional adducts
of platinum complexes can be prematurely terminated at the
level or in the proximity of adducts (Corda et al., 1991,
1992; Lemaire et al., 1991; Brabec and Leng, 1993; Brabec
et al., 1994; Nova´kova´ et al., 1995; Zˇaludova´ et al., 1997).
Importantly, monofunctional DNA adducts of several plat-
inum complexes are unable to terminate RNA synthesis.
Cutting of pSP73KB DNA (Lemaire et al., 1991) by NdeI
and HpaI restriction endonucleases yielded a 212-bp frag-
ment (a substantial part of its nucleotide sequence is shown
in Fig. 2 B). This fragment contained convergent T7 and
SP6 RNA polymerase promoters [in the upper and lower
strands, respectively, close to its 3-ends (Fig. 2 B)]. The
experiments were carried out using this linear DNA frag-
ment, modified by Pt-DAB(RR), Pt-DAB(SS), or cisplatin
at rb  0.01, for RNA synthesis by T7 and SP6 RNA
polymerases (Fig. 2 A, lanes RR, SS or cisDDP, respective-
ly). RNA synthesis on the template modified by the plati-
num complexes yielded fragments of defined sizes, which
indicates that RNA synthesis on these templates was pre-
maturely terminated. The major stop sites produced by both
Pt-DAB complexes were identical to those produced by
cisplatin, and the corresponding bands produced by both
enantiomers and cisplatin on the autoradiogram had similar
intensity. The sequence analysis revealed that the major
bands resulting from termination of RNA synthesis by the
adducts of Pt-DAB(RR), Pt-DAB(SS), and cisplatin were
identical and appeared at G sites and in a considerably less
extent at A sites. These G and A sites were mostly contained
in GG or AG sites, which are preferential DNA binding sites
for untargeted cisplatin. Taken together, the results of the
transcription mapping experiments suggest that base se-
quence selectivity of Pt-DAB(RR), Pt-DAB(SS), and cis-
platin are similar.
Interstrand cross-linking
The experiments of the present work were carried out to
compare the amounts of the interstrand cross-links formed
by Pt-DAB(RR) or Pt-DAB(SS) in linear DNAs. We used in
these experiments pSP73KB plasmid (2455 bp) modified by
Pt-DAB complexes after it had been linearized by EcoRI
(EcoRI cuts only once within pSP73KB plasmid). The sam-
ples were analyzed for the interstrand cross-links by agarose
gel electrophoresis under denaturing conditions.
An electrophoretic method for precise and quantitative
determination of interstrand cross-linking by platinum com-
plexes in DNA was described previously (Farrell et al.,
1990; Lemaire et al., 1991; Brabec and Leng, 1993). Upon
electrophoresis under denaturing conditions, 3-end-labeled
strands of linearized pSP73KB plasmid containing no inter-
FIGURE 2 Inhibition of RNA synthesis by T7 (left) and SP6 (right)
RNA polymerases on the NdeI/HpaI fragment of pSP73KB plasmid mod-
ified by platinum complexes. (A) Autoradiogram of 6% polyacrylamide/8
M urea sequencing gel. Lanes: control, nonmodified template; cisDDP;
RR; SS, the template modified by cisplatin; Pt-DAB(RR), Pt-DAB(SS) at
rb  0.01, respectively. (B) Schematic diagram showing the portion of the
nucleotide sequence of the template (upper) strand of the NdeI/HpaI
fragment used to monitor inhibition of RNA synthesis by platinum com-
plexes. The arrows indicate the start of the T7 or SP6 RNA polymerases.
(E), major stop signals (from A) for DNA modified by Pt-DAB(RR). The
numbers correspond to the nucleotide numbering in the sequence map of
the pSP73KB plasmid.
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strand cross-links migrate as a 2455-nucleotide single
strand, whereas the interstrand cross-linked strands migrate
more slowly as a higher molecular mass species. The bands
corresponding to more slowly migrating interstrand-cross-
linked fragments were noticed if either Pt-DAB complex
was used to modify DNA at rb as low as 310
4 (Fig. 3 A).
The intensity of the more slowly migrating band increased
with the growing level of the modification. The radioactiv-
ity associated with the individual bands in each lane was
measured to obtain estimates of the fraction of non-cross-
linked or cross-linked DNA under each condition. The
frequency of interstrand cross-links (the amount of inter-
strand cross-links per one molecule of Pt-DAB complex
coordinated to DNA) was calculated using the Poisson
distribution in combination with the rb values and the frag-
ment size (Farrell et al., 1990) (for details see also Materials
and Methods).
As summarized in Fig. 3 B, both Pt-DAB complexes
showed a relatively low but significant interstrand cross-
linking efficiency in linear DNA (at rb  0.001, approxi-
mately 6%). There was no significant difference between
the yields of DNA interstrand cross-linking by Pt-DAB
enantiomers. Thus, these results indicate that the interstrand
cross-links are only minor adducts in double-helical DNA
modified by Pt-DAB complexes which are formed with a
similar frequency like the same lesions of cisplatin. This
observation is consistent with an idea that the spectrum of
adducts produced on DNA by the two Pt-DAB compounds
is similar for each enantiomer and similar to that reported
for cisplatin (Brabec and Leng, 1993; Vra´na et al., 1996) or
for other analogs such as cis-[PtCl2(DACH)] complexes
(Boudny´ et al., 1992; Brabec, unpublished results).
Taken together, the results of the interstrand cross-linking
assay and transcription mapping experiments are consistent
with the idea that the replacement of NH3 nonleaving li-
gands in cisplatin by the DAB carrier ligand in both enan-
tiomeric forms (RR or SS) has not significantly altered base
sequence selectivity of the parent platinum drug or the
spectrum of its DNA adducts.
Conformational changes produced in double-
helical DNA by the site-specific d(GpG)
intrastrand cross-link
The major DNA lesion of cisplatin and its simple analogs
with different carrier amines is the 1,2-d(GpG) intrastrand
adduct (Jennerwein et al., 1989; Page et al., 1990 and vide
supra). The goal of our further work was to establish
whether the steric structure of the non-leaving group of
platinum DAB enantiomers could influence the distortions
induced in DNA by the formation of the 1,2-d(GpG) intra-
strand cross-link. We directed our further studies on estab-
lishing distortions and other biophysical properties of oli-
godeoxyribonucleotide duplexes containing a single, site-
specific 1,2-d(GpG) intrastrand cross-link of Pt-DAB(RR)
or Pt-DAB(SS).
Differential scanning calorimetry
A calorimetric technique was used to characterize the influ-
ence of the 1,2-d(GpG) intrastrand cross-link of Pt-
DAB(RR) or Pt-DAB(SS) on the thermal stability and en-
ergetics of the site-specifically platinated 20-mer DNA
duplex. Such thermodynamic data can reveal how the plat-
inum adduct influences duplex stability, a property that has
been shown to play a significant role in the mechanism of
antitumor activity of platinum drugs. Recently, calorimetric
and spectroscopic techniques were used to characterize the
influence of the 1,2-d(GpG) intrastrand cross-link on the
thermal stability and energetics of a 20-mer DNA duplex
site-specifically modified by cisplatin (Poklar et al., 1996).
We expanded these studies on the oligodeoxyribonucleotide
duplex containing unique 1,2-d(GpG) site-specific intrastrand
adducts of the Pt-DAB(RR) or Pt-DAB(SS) complexes.
Fig. 4 shows DSC melting profiles (Cp versus T) for the
parent, nonmodified 20 bp duplex d(TGGT(/d(ACCA)(20-
FIGURE 3 The formation of interstrand cross-links by Pt-DAB com-
pounds in linearized pSP73KB plasmid. (A) Autoradiograms of a denatur-
ing 1.5% agarose gel of linearized DNA, which was 3-end-labeled; the
interstrand cross-linked DNA appears as the top bands migrating on the
gels more slowly than the single-stranded DNA (contained in the bottom
bands); the plasmid linearized by EcoRI was incubated with Pt-DAB(RR)
(top) or Pt-DAB(SS) (bottom) for 48 h at 37°C. Lanes: C, control, non-
modified DNA (rb  0); 1, rb  3  10
4; 2, rb  6  10
4; 3, rb  9 
104; 4, rb  1.2  10
3. (B) Dependence on rb of the percentage of
interstrand cross-links per adduct [interstrand cross-linking (%)] formed by
Pt-DAB(RR) (F) or Pt-DAB(SS) (E) in linearized DNA within 48 h. Data
measured in triplicate varied on average 
3% from their mean.
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DSC) (solid curve) and the same duplex containing single
1,2-d(GpG) intrastrand cross-link of Pt-DAB(RR) (dashed
curve) or Pt-DAB(SS) (dotted curve). These curves were
analyzed as described in Material and Methods to obtain the
results listed in Table 1. Inspection of these thermodynamic
parameters reveals a number of interesting features. First,
cross-link formation of Pt-DAB(RR) and Pt-DAB(SS) re-
duced the duplex thermal stability by 6.9°C and 8.6°C,
respectively. Second, cross-link formation by Pt-DAB(RR)
and Pt-DAB(SS) resulted in a large increase of the enthalpy
of duplex formation by 36 and 38 kcal/mol, respectively. In
other words, the intrastrand cross-link of Pt-DAB enanti-
omers enthalpically destabilizes the duplex relative to their
nonmodified counterpart. Third, cross-link formation by
Pt-DAB(RR) and Pt-DAB(SS) resulted in a substantial in-
crease in duplex transition entropy of 104 or 107 cal/K.mol
(TS  31.0 or 31.9 kcal/mol at 25°C), respectively. In
other words, the intrastrand cross-link of both DAB enan-
tiomers entropically stabilizes the duplex. Thus, the 36 or 38
kcal/mol enthalpic destabilization of the duplex due to the
cross-link of Pt-DAB(RR) or Pt-DAB(SS), respectively is
partially, but not completely, compensated by the entropic
cross-link-induced stabilization of the duplex of 31 or 32
kcal/mol at 25°C, respectively. The net result of these
enthalpic and entropic effects is that 1,2-d(GpG) intrastrand
cross-link formation by Pt-DAB(RR) or Pt-DAB(SS) at
25°C induces a decrease in duplex thermodynamic stability
(G25) of 5.0 or 7.6 kcal/mol, respectively, with this
destabilization being enthalpic in origin. In this respect, the
intrastrand cross-link of Pt-DAB(SS) was more effective
than that of its RR counterpart.
Chemical probing of conformational distortions
Cyanide ions can rapidly remove cisplatin and its analogs
from double-helical oligonucleotides containing 1,2-
d(GpG) intrastrand cross-links of these platinum com-
pounds. It has been shown (Schwartz et al., 1990; Boudny´
et al., 1992) that the kinetics of the reaction between cya-
nide ions and the d(GpG) intrastrand cross-link of cisplatin
and its analogs is strongly dependent on the DNA confor-
mation. The samples of d(TGGT)/d(ACCA) containing the
intrastrand cross-link of Pt-DAB(RR) or Pt(DAB)(SS) were
treated with a large excess of cyanide ions. At various times,
aliquots were withdrawn and analyzed by gel electrophore-
sis under denaturing conditions (Schwartz et al., 1990;
Boudny´ et al., 1992) (Fig. 5, A and B). As judged by the
disappearance of the starting products (upper bands), cya-
nide ions were considerably less reactive with the double-
stranded oligonucleotide containing the intrastrand cross-
link of Pt-DAB(SS) as compared with that containing the
same adduct of Pt-DAB(RR) (Fig. 5 C). It has been shown
that the rate of removal of the bound platinum residues
decreases when the distortion induced by the Pt-d(GpG)
adduct is larger (Schwartz et al., 1990; Boudny´ et al., 1992).
Thus, the results shown in Fig. 5 support the idea that the
1,2-d(GpG) intrastrand cross-link of Pt-DAB(SS) induces in
FIGURE 4 DSC thermograms for the d(TGGT)/d(ACCA)(20-DSC) du-
plex nonmodified (solid curve), containing the 1,2-d(GpG) intrastrand
cross-link of Pt-DAB(RR) (dashed curve), or Pt-DAB(SS) (dotted curve).
The duplex concentrations were 5 M, and the buffer conditions were 10
mM sodium cacodylate (pH 7.2), 100 mM NaCl, 10 mM MgCl2, and 0.1
mM EDTA.
TABLE 1 Thermodynamic parameters for formation of the oligonucleotide duplex d(TGGT)/d(ACCA)(20-DSC) nonplatinated or
containing the 1,2-d(GpG) intrastrand cross-link of Pt-DAB(RR) and Pt-DAB(SS) determined by DSC
Duplex Tm, °C H°, kcal/mol duplex S°, cal/K  mol duplex G°25,* kcal/mol duplex
no Pt 68.3 151 
 8 446 
 23 18.0 
 1.9
Pt-DAB(RR) 61.4 115 
 7 342 
 19 13.0 
 1.3
Pt-DAB(SS) 59.7 113 
 8 339 
 18 10.3 
 1.3
Calorimetric measurements were conducted as described in the text. The H° and S° values are averages derived from three independent experiments,
with the indicated errors corresponding to the average deviation from the mean.
*G°25 is the free energy of duplex formation at 25°C, as determined using the equation
G25 H 298.15S (2)
The indicated uncertainties reflect the maximum possible errors in G°25 that result from the corresponding uncertainties noted above in H° and S°, as
propagated through Eq. 2.
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DNA a larger conformational distortion than its RR coun-
terpart. These results are also consistent with the DSC
analysis (Fig. 4 and Table 1), which indicated a larger
thermal and thermodynamic destabilization induced in
DNA by the 1,2-d(GpG) intrastrand cross-link of Pt-
DAB(SS) in comparison with the cross-link of Pt-
DAB(RR).
To further characterize the distortion induced in DNA by
intrastrand cross-links of Pt-DAB(RR) or Pt-DAB(SS), the
d(TGGT)/d(ACCA)(20) containing the 1,2-d(GpG) intra-
strand cross-link of Pt-DAB(RR) or Pt-DAB(SS) was
treated with several chemical agents that are used as tools
for monitoring the existence of conformations other than
canonical B-DNA. These agents include KMnO4, DEPC,
and bromine. They react preferentially with single-stranded
DNA and distorted double-stranded DNA (Nielsen, 1990;
Brabec et al., 1993; Bailly et al., 1994; Ross and Burrows,
1996; Bailly and Waring, 1997).
KMnO4 is hyperreactive with thymine residues in single-
stranded nucleic acids and in distorted DNA as compared to
B-DNA (McCarthy et al., 1990; McCarthy and Rich, 1991;
Bailly et al., 1994; Bailly and Waring, 1997). KMnO4
reacted with no residue within the nonplatinated duplex
(Fig. 6A, left, lane ds). All thymine residues were strongly
reactive in the nonplatinated single-stranded top oligonucle-
otide (Fig. 6 A, left, lane ss). The duplex containing the
intrastrand cross-link of Pt-DAB(RR) showed strong reac-
tivity of the 5 and 3 thymine residues adjacent to the
adduct (Fig. 6 A, left, lane RR). A weak but significant
reactivity was also observed for the second 5 thymine
residue adjacent to the cross-link. The duplex containing the
intrastrand cross-link of Pt-DAB(SS) showed strong reac-
tivity of the two neighboring 5 thymine residues in the top
strand adjacent to the adduct, and a weak but significant
reactivity was also observed for the 3 thymine residue
adjacent to the cross-link (Fig. 6 A, left, lane SS). No
reactivity between KMnO4 and the residues in the bottom
strand of the cross-linked duplexes was apparent.
DEPC carbetoxylates purines at the N(7) position. It is
hyperreactive with unpaired and distorted adenine residues
in DNA and with left-handed Z-DNA (Herr, 1985; Johnston
and Rich, 1985; Bailly et al., 1994; Bailly and Waring,
1997). Adenine and guanine residues within the nonplati-
nated single-stranded oligonucleotides (top and bottom)
readily reacted with DEPC (shown for the bottom strand in
Fig. 6 A, center, lane ss). No reactivity of adenine and
guanine residues was observed within the nonplatinated
double-stranded oligonucleotide (shown in Fig. 6 A, center
for the bottom strand, lane ds). Within the double-stranded
oligonucleotide containing the intrastrand cross-link of Pt-
DAB(RR) or Pt-DAB(SS), three base residues in the bottom
strand became reactive (Fig. 6 A, center, lanes RR and SS):
these are readily identified as the three adenine residues
complementary to the reactive thymine residues of the top
strand. Importantly, a strong reactivity with DEPC was only
observed for adenine residues complementary to strongly
reactive thymine residues, whereas adenine residues com-
plementary to weakly reactive thymine residues also reacted
with DEPC only weakly.
Bromination of cytosine and formation of piperidine-
labile sites are observed when two simple salts, KBr and
KHSO5, are allowed to react with single-stranded or dis-
torted double-stranded oligonucleotides (Ross and Burrows,
1996). The reaction proceeds via generation of Br2 in situ,
which reacts selectively with the 5,6 double bond to add Br
and OH, respectively. H2O is then eliminated to give 5-bro-
modeoxycytidine, which is susceptible to depyrimidination
under basic conditions. All cytosine residues within the
nonplatinated top and bottom strands of d(TGGT)d(ACCA)
were readily reactive (shown for the bottom strand in Fig. 6
A, right, lane ss). No reactivity of these residues was ob-
FIGURE 5 Autoradiograms of a denaturing 24% polyacrylamide gel of
the products of the reaction between cyanide ions and the oligonucleotide
duplex d(TGGT)/d(ACCA)(20) containing a single 1,2-d(GpG) intrastrand
cross-link of Pt-DAB(RR) (A) or Pt-DAB(SS) (B). The platinated samples
at the concentration of 3 106 M were incubated at 37°C and in 0.2 M
NaCN, 20 mM Tris  HCl adjusted at pH 8.3 by addition of HCl. At various
times, the samples were precipitated with ethanol, washed three times with
ethanol, and electrophoresed. Lanes: C, control, nonmodified duplex; 1–9
correspond to the following times (in hours) of incubation of the platinated
duplex with NaCN: 1, 0.0; 2, 0.25; 3, 0.5; 4, 0.75; 5, 1.0; 6, 1.5; 7, 2; 8, 3.5;
9, 5.3. The top strand of the d(TGGT)/d(ACCA) was 32P-end-labeled at the
5 end. (C) The dependence of the amount of platinum coordinated to the
oligonucleotide duplex d(TGGT)/d(ACCA)(20) containing single intras-
trand cross-link of Pt-DAB(RR) (F) or Pt-DAB(SS) (E) on the time of
incubation with NaCN. The experimental conditions were the same as in A
and B.
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served within the nonplatinated duplex (shown for the bot-
tom strand in Fig. 6 A, right, lane ds). Cytosine residues in
the bottom strand complementary to the platinated guanine
residues in the top strand containing the intrastrand cross-
links of Pt-DAB(RR) or Pt-DAB(SS) were, however,
strongly reactive.
The results obtained with chemical probes are summa-
rized in Fig. 6 B. The pattern and degree of reactivity toward
the chemical probes was different for the two Pt-DAB
isomers indicating different character of the conformational
distortion. In addition, the results suggest that the confor-
mational distortion extends over at least five basepairs
around the cross-link.
DNA unwinding and bending
Among the alterations of secondary and tertiary structure of
DNA to which it may be subject, the role of intrinsic
bending and unwinding of DNA is increasingly recognized
as being potentially important in regulating replication and
transcription functions through specific DNA-protein inter-
actions. For cisplatin adducts, the structural details respon-
sible for bending and subsequent protein recognition have
recently been elucidated (Ohndorf et al., 1999; Zamble and
Lippard, 1999). Given the recent advances in our under-
standing of the structural basis for the bending of DNA
caused by cisplatin, it is of considerable interest to examine
how the character of a carrier amine in the 1,2-d(GpG)
intrastrand adduct affects conformational properties of
DNA, such as bending and unwinding. In this work we
further performed studies on the bending and unwinding
induced by single, site-specific intrastrand cross-links of
Pt-DAB enantiomers formed in oligodeoxyribonucleotide
duplexes between neighboring guanine residues.
The top strands of the oligonucleotide duplexes examined
in the present work were designed to contain only one
high-affinity platinum binding site, the two adjacent gua-
nine bases of the intrastrand cross-link (Fig. 1). All se-
quences were designed to leave a 1 nucleotide overhang at
their 5-ends in double-stranded form. These overhangs
facilitate polymerization of the monomeric oligonucleotide
duplexes by T4 DNA ligase in only one orientation, and
maintain a constant interadduct distance throughout the
resulting multimer. Autoradiograms of electrophoresis gels
revealing resolution of the ligation products of 20–23-bp
duplexes containing a unique 1,2-d(GpG) intrastrand cross-
link of Pt-DAB(RR) or Pt-DAB(SS) are shown in Fig. 7. A
significant retardation was observed for the multimers of all
platinated duplexes. Decreased gel electrophoretic mobility
FIGURE 6 (A) Piperidine-induced specific strand cleavage at KMnO4-
modified (left), diethylpyrocarbonate-modified (center), and KBr/KHSO5-
modified (right) bases in nonplatinated and platinated d(TGGT)/
d(ACCA)(20). The oligomers were 5-end-labeled at their top strands in
the case of the modification by KMnO4 or at their bottom strands in the
case of the modification by DEPC or KBr/KHSO5. KMnO4 (left): the lane
ss is relative to the nonplatinated top strand. The lane ds is relative to the
nonplatinated duplex. The lane G is a Maxam-Gilbert specific reaction for
the nonplatinated duplex that had only top strand end-labeled. The lanes SS
and RR are relative to the duplex containing Pt-DAB(SS) or Pt-DAB(RR)
1,2-d(GpG) intrastrand cross-link, respectively. DEPC (center): The lane G
is a Maxam-Gilbert specific reaction for the nonplatinated duplex that had
only bottom strand end-labeled. The lane ds is relative to the nonplatinated
duplex. The lane ss is relative to the nonplatinated bottom strand. The lanes
SS and RR are relative to the duplex containing Pt-DAB(SS) or Pt-
DAB(RR) 1,2-d(GpG) intrastrand cross-link, respectively. KBr/KHSO5
(right): The lane G is a Maxam-Gilbert specific reaction for the nonplati-
nated duplex. The lane ds is relative to the nonplatinated duplex. The lane
ss is relative to the nonplatinated bottom strand that had only bottom strand
end-labeled. The lanes SS and RR are relative to the duplex containing
Pt-DAB(SS) or Pt-DAB(RR) 1,2-d(GpG) intrastrand cross-link, respec-
tively, that had only bottom strand end-labeled. (B) Summary of the
reactivity of chemical probes; F and E designate strong or weak reactivity,
respectively.
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may result from a decrease in the DNA end-to-end distance
(Koo and Crothers, 1988). Various platinum(II) complexes
have been shown to form DNA adducts that decrease gel
mobility of DNA fragments due to either stable curvature of
the helix axis or increased isotropic flexibility (Rice et al.,
1988; Bellon and Lippard, 1990; Leng, 1990; Brabec et al.,
1993; Huang et al., 1995; Malinge et al., 1995). DNA
multimers of identical length and number of stable bend
units, but with differently phased bends, have different
end-to-end distances. The DNA bends of a multimer must
be, therefore, spaced evenly and phased with the DNA
helical repeat in order to add constructively. Such construc-
tively phased bends add in plane, yielding short end-to-end
distances and the most retarded gel migration. In other
words, gel electrophoresis of multimers of oligonucleotide
duplexes, which only differ in length and contain a stable
curvature induced by the same platinum adduct, should
exhibit a phase effect, i.e., the maximum retardation should
be observed for the multimers having the bends in phase
with the helix screw. In contrast, the normal electrophoretic
mobility should be observed for the multimers having the
bends separated by a half-integral number of DNA turns.
The K factor is defined as the ratio of calculated to actual
length. The calculated length is based on a multimer’s
mobility, and is obtained from a calibration curve con-
structed from the mobilities of nonplatinated multimers.
The variations of the K factor versus sequence length ob-
tained for multimers of the duplexes 20–23 bp long and
containing the unique 1,2-d(GpG) intrastrand cross-link of
Pt-DAB(RR) or Pt-DAB(SS) are shown in Fig. 8 B. Max-
imum retardation was observed for the 22-bp duplex con-
taining the adduct of Pt-DAB(RR) (Fig. 8 B, left). This
observation suggests that the natural 10.5-bp repeat of B-
DNA and that of DNA perturbed by the Pt-DAB(RR) in-
trastrand cross-link are different as a consequence of DNA
unwinding (Bellon et al., 1991). Similarly, in the case of the
duplex containing the adduct of Pt-DAB(SS), maximum
retardation was observed for the 21-bp duplex, but the 22-bp
curve had only a slightly smaller slope, whereas the 20-bp
curve differed more pronouncedly (Fig. 8 B, right). This
asymmetry is also consistent with a significant DNA un-
winding due to the formation of the cross-link by the SS
enantiomer.
The exact helical repeat of the intrastrand cross-linked
duplex and from it the unwinding angle were calculated by
interpolation with the use of the K versus interadduct dis-
tance curve as described in the previous paper for intras-
trand adducts of cisplatin (Bellon et al., 1991). The maxi-
mum of these curves constructed for the duplexes
FIGURE 7 Autoradiograms of the ligation products of double-stranded
oligonucleotides d(TGGT)d(ACCA)(20–23) containing a unique 1,2-
d(GpG) intrastrand cross-link of Pt-DAB(RR) or Pt-DAB(SS) separated on
an 8% polyacrylamide gel (lanes RR and SS, respectively). Nonplatinated
oligomers, lanes NoPt.
FIGURE 8 (A) Plots showing the relative mobility K versus interadduct
distance in bp for the oligomers d(TGGT)/d(ACCA)(20–23) modified by
Pt-DAB(RR) (left) or Pt-DAB(SS) (right) with a total length of 140 bp. The
experimental points represent the average of three independent electro-
phoresis experiments. The curves represent the best fit of these experimen-
tal points to the equation K  ad2  bd  c (Bellon et al., 1991). (B) Plots
showing the relative mobility K versus sequence length curves for the
oligomers d(TGGT)/d(ACCA)(20–23), denoted respectively as 20, 21, 22,
and 23.
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intrastrand cross-linked by Pt-DAB(RR) or Pt-DAB(SS)
with a total length of 140 bp (Fig. 8 B) were determined to
be 21.57
 0.01 or 21.44
 0.04 bp. Total sequence lengths
other than 140 bp were examined and gave identical results.
To convert the interadduct distance in basepairs correspond-
ing to the curve maximum into a duplex unwinding angle in
degrees, the value is compared with that of the helical repeat
of B-DNA, which is 10.5 
 0.05 bp (Wang, 1979; Rhodes
and Klug, 1980). The difference between the helical repeat
of B-DNA and the DNA containing intrastrand cross-link of
Pt-DAB(RR) or Pt-DAB(SS) complex, therefore, is
[(21.57 
 0.01)  2(10.5 
 0.05)]  0.57 
 0.06 bp or
[(21.44 
 0.04)  2(10.5 
 0.05)]  0.44 
 0.09 bp,
respectively. There are 360°/10.5 bp, so the DNA unwind-
ing due to one intrastrand adduct of Pt-DAB(RR) or Pt-
DAB(SS) is 20 
 2° or 15 
 3°, respectively. These
unwinding angles are considerably greater than that found
for the 1,2-d(GpG) intrastrand cross-link of cisplatin (13°)
using the same experimental procedure (Bellon et al., 1991).
One plausible explanation of this observation might be
associated with an additional contribution to unwinding
associated with interaction of the DAB moiety with the
duplex upon covalent binding of platinum. In a similar way,
large unwinding angles (19°) produced by cisplatin teth-
ered to intercalators were explained (Keck and Lippard,
1992).
The appreciation of the relationship between interadduct
distance and phasing for self-ligated multimers composed of
the identical number of monomeric duplexes (bend units)
resulted in a bell-shaped pattern (Fig. 8 B) characteristic for
bending (Rice et al., 1988; Bellon and Lippard, 1990; Leng,
1990; Brabec et al., 1993; Huang et al., 1995; Malinge et al.,
1995). The quantitation of the bend angle of the intrastrand
cross-links of Pt-DAB(RR) or Pt-DAB(SS) complexes was
performed in the way described previously (Rice et al.,
1988; Bellon and Lippard, 1990; Leng, 1990; Brabec et al.,
1993; Huang et al., 1995; Malinge et al., 1995) utilizing the
empirical equation
K 1 9.6 105L2 0.47RC2 (1)
where L represents the length of a particular oligomer with
relative mobility K and RC the curvature relative to a DNA
bending induced at the tract of six adenines (A6 tract) (Rice
et al., 1988). Application of Eq. 1 to the 132- or 154-bp
multimers of the 22-bp oligomers containing the single
intrastrand cross-link of Pt-DAB(RR) leads to curvatures of
0.87, relative to an A6 tract. Similarly, the application of Eq.
1 to the 126- or 147-bp multimers of the 21-bp oligomers
containing the single intrastrand cross-link of Pt-DAB(RR)
leads to curvatures of 0.57, relative to an A6 tract. The
average bend angle per helix turn can be calculated by
multiplying the relative curvature by the absolute value of
an A6 tract bend [20° (Bellon and Lippard, 1990; Koo et al.,
1990)]. The results indicate that the bends induced by the
intrastrand cross-link of Pt-DAB(RR) or Pt-DAB(SS) are
35° or 24°, respectively. That these bands were oriented
toward the major groove of DNA was verified in the same
way as in the previously published paper (Huang et al.,
1995). Other details of the calculations of the unwinding
and bending angles are given in the previously published
papers (Rice et al., 1988; Bellon and Lippard, 1990; Leng,
1990; Brabec et al., 1993; Huang et al., 1995; Malinge et al.,
1995).
Also produced in ligations of monomers investigated in
this work were separate bands arising from small DNA
circles that migrate close to the top of the gel (see the bands
marked by asterisk in Fig. 7 as example). The highest
tendency to yield DNA circles was observed for the 22-bp
multimers confirming a close match between the 22-bp
sequence repeat and the helix screw (Ulanovsky et al., 1986;
Rice et al., 1988).
DISCUSSION
The results of the present work (Figs. 2 and 3) are consistent
with the view that the replacement of NH3 nonleaving
ligands in cisplatin by the DAB carrier ligand in both
enantiomeric forms (RR or SS) changes neither the spec-
trum and frequency of DNA adducts nor the sequence
selectivity of DNA binding of the parent drug. Thus, these
features of DNA binding mode of Pt-DAB compounds are
unlikely to be associated with the different biological activ-
ity of these platinum compounds. A possible explanation for
the different biological activity of Pt-DAB enantiomers can
be associated with the different conformational distortions
induced in DNA by the adducts of these compounds and
their different processing in the cell. To test this hypothesis,
the experiments described in the present work were carried
out.
Thermal and thermodynamical stability of duplexes con-
taining single, site-specific 1,2-d(GpG) intrastrand adduct
of either Pt-DAB enantiomer (this cross-link is the major
DNA adduct of cisplatin and its direct analogs) and the
resistance of this adduct to NaCN treatment demonstrate
that the lesions formed by Pt-DAB(SS) were more effective
at inducing overall destabilization of the duplex and global
conformational alterations than those formed by Pt-
DAB(RR). This result is consistent with the idea and sup-
ports the hypothesis that the enhancement of mutagenic
activity of Pt-DAB(SS) compound is associated with an
increase of the thermodynamical destabilization of the du-
plex and the character of the overall or global conforma-
tional alteration induced by this platinum compound in
DNA.
The character of global conformational distortions and
alterations of the overall stability of the double-helical DNA
induced by its damage are determined by the sum of indi-
vidual contributions from various features of the damage.
Some of these individual features may result in stabilization
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of the duplex, others may lower its stability. An important
feature of the local conformational distortion induced by the
1,2-d(GpG) adduct of cisplatin and its analogs is bending of
the duplex axis (Bellon and Lippard, 1990; Takahara et al.,
1996; Gelasco and Lippard, 1998). The results of the
present work indicate that bending and unwinding angles
due to the Pt-DAB(SS) cross-link are smaller than those due
to the cross-link of Pt-DAB(RR). However, the overall
destabilization of the duplex due to the cross-link of Pt-
DAB(SS) is greater than that due to the cross-link of Pt-
DAB(RR). It was suggested recently (Poklar et al., 1996)
that helical bending induced by the 1,2-d(GpG) intrastrand
cross-link of cisplatin thermodynamically stabilized the du-
plex. A crude estimate has indicated that helical bending
due to cisplatin-1,2-d(GpG) cross-link contributed 6.4
kcal/mol toward stabilization of the global duplex structure.
Thus, helical bending induced by the d(GpG) intrastrand
cross-link has been suggested (Poklar et al., 1996) to par-
tially compensate destabilization due to the formation of
this adduct. With this qualification in mind, we suggest that
one reason why the intrastrand cross-link of Pt-DAB(SS)
globally destabilizes the DNA duplex more efficiently than
the same cross-link of the RR enantiomer is also associated
with a lower efficiency of the adduct of the SS enantiomer
to contribute toward stabilization of the global duplex struc-
ture associated with the bending.
Another conformational parameter of the distortion in-
duced by the formation of the 1,2-d(GpG) intrastrand cross-
links of Pt-DAB compounds determined in the present work
was unwinding of the double helix (lowering of the number
of basepairs per a helical turn). The adduct of the RR
enantiomer was slightly more effective in DNA unwinding
than the cross-link of its SS counterpart. The energetics of
DNA unwinding can be crudely estimated using the same
approach as that used to calculate the free energy required to
twist a DNA fragment 12 bp long containing a single
1,2-(GpG) intrastrand adduct of cisplatin about its helix axis
(Bellon et al., 1991). The free energy of unwinding of only
0.29 kcal/mol was calculated assuming the unwinding angle
13° (Bellon et al., 1991). The same calculations were per-
formed, assuming unwinding angles of 20° for the cross-
link of Pt-DAB(RR), 15° for the cross-link of Pt-DAB(SS)
(vide supra), and local twisting within the fragment 20 bp
long [the fragment 20 bp long was taken for these calcula-
tions because energetics of the duplex of this length con-
taining the single, site-specific intrastrand d(GpG) cross-
link of Pt-DAB enantiomers was characterized in the
present work (Fig. 4 and Table 1)]. These approximate
calculations gave free energies of unwinding of only 0.42
and 0.23 kcal/mol, respectively. If this rough estimate is
justified, then it seems reasonable to suggest that unwinding
due to the intrastrand cross-link of Pt-DAB compounds
contributes to the efficiency of these platinum complexes to
affect the overall stability of the duplex only in a very small
extent. More detailed proposals as to the exact nature of the
effect of unwinding induced in DNA by the 1,2-d(GpG)
intrastrand cross-link of Pt-DAB compounds must await the
results of further experiments.
The structural perturbation caused by d(GpG) intrastrand
cross-links of cisplatin has been subjected to numerous
NMR investigations, which were recently reviewed (Ano et
al., 1999). In these adducts, the polynucleotide chain con-
fines the guanine to a head-to-head (HH) arrangement
(Sherman and Lippard, 1987; Bloemink and Reedijk, 1996).
The preferential orientations of the guanines in the HH
conformation are those with one guanine close to perpen-
dicular to the coordination plane (Ø  100–110°) and the
other rather tilted and forming a hydrogen bond between its
carbonyl oxygen atom and the NH3 group in cis position
(Ø  50–60°) (Kozelka et al., 1992). The tilting will be
greater for hydrogen bond formation between the carbonyl
oxygen of the guanine residue and a “quasi equatorial”
hydrogen of the cis amine (Grabner et al., 1998). Molecular
models indicate that one “quasi equatorial” amino proton of
the Pt-DAB(SS)-[d(GpG)] cross-link is close to O(6)-5
(carbonyl oxygen of the 5-guanosine) and that one “quasi
equatorial” amino proton of Pt-DAB(RR)-[d(GpG)] is close
to O(6)-3 (carbonyl oxygen of the 3-guanosine). Conse-
quently, the formation of the Pt-DAB(SS)-d(GpG) cross-
link is expected to give greater tilt of the guanine residue on
the 5 side, and therefore the greater distortion on the 5 side
of the cross-link. In contrast, formation of the Pt-DAB(SS)-
d(GpG) cross-link should result in the greater tilt for the
guanine residue on the 3 side, so that the distortion should
be greater on the 3 side of the cross-link.
These assumptions are in good agreement with the results
of the experiments in which structural changes in DNA
induced by the single, site-specific 1,2-d(GpG) intrastrand
cross-link of Pt-DAB(RR) or Pt-DAB(SS) were investi-
gated by studying the effect of this cross-link on the reac-
tivity of KMnO4 and DEPC toward DNA. KMnO4 and
DEPC are complementary probes capable of revealing the
location of AT basepairs, the secondary structure of which
has been perturbed by the cross-link. Importantly, these
chemical probes do not represent measures of basepair
disruption as they can proceed even if the basepairing is
maintained (Bailly et al., 1994). Formation of adducts by
these probes requires out-of-plane attack by the electrophile
so that they will be sterically hindered by stacking of
neighboring basepairs. Thus, KMnO4 and DEPC are essen-
tially probes of base stacking (Bailly et al., 1994) so that
they are particularly suitable for proving distortions induced
by the cross-links of Pt-DAB enantiomers predicted above.
If the reactivity of the two chemical probes with the du-
plexes containing the cross-links of Pt-DAB(RR) or Pt-
DAB(SS) is compared (Fig. 6), the duplex containing the
cross-link of Pt-DAB(RR) shows considerably stronger re-
activity of the AT basepair whose thymine residue is adja-
cent to the adduct on its 3 side. In contrast, the duplex
containing the intrastrand adduct of Pt-DAB(SS) shows
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stronger reactivity of the two probes of the AT basepair on
the other side of the adduct (particularly the second AT
basepair 5 to the adduct). Thus, the results obtained with
the aid of these chemical probes highlight the importance of
hydrogen bond formation between the carbonyl oxygen of
the guanine residue and a “quasi equatorial” hydrogen of the
cis amine as discussed above.
In conclusion, the excellent agreement between the pre-
visions and the results of the present work demonstrates the
potentiality of the techniques of molecular biophysics in
highlighting very fine structural modifications, such as
those promoted on DNA by enantiomeric Pt-DAB com-
pounds. Importantly, the configuration of the asymmetric
carbons in these complexes dictates the conformation of the
chelate ring (-gauche and 	-gauche for the SS and RR
isomer, respectively) and thus the “axial” or “equatorial”
disposition of the hydrogen atoms on the coordinated nitro-
gen atoms. Also importantly, formation of hydrogen bonds
between the carbonyl oxygen of the guanine residue and the
“quasi equatorial” hydrogen of the cis amine determines
propagation of the distortion of double-helical structure
either on the 3 or on the 5 side of the cross-linked bases,
depending on the configuration of the carrier ligand.
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